Clinical Trial Update: High Dose Ascorbic Acid for Plasma Cell Disorders [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating high-dose ascorbic acid (vitamin C) in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• High Dose Ascorbic Acid (ascorbic acid)

Snippet

Sponsor: Christopher Strouse | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED